Browse Pet Safety Reports
15,441 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 15,441 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 15,441 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 1, 2024 | Dog | Retriever - Labrador | Isoflurane | Walking difficulty; Limb weakness; Hypophosphataemia; Proprioception loss; Pa... | Ongoing |
| Jun 1, 2024 | Dog | Mountain Dog - Bernese | Bedinvetmab | Death by euthanasia; Limb weakness; Muscle wasting; Incoordination; Abnormal ... | Euthanized |
| Jun 1, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Polyuria; Polydipsia; Not eating; Weakness; Loose stool; Hypercalcaemia; Elev... | Ongoing |
| Jun 1, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Limb weakness; Myelopathy NOS | Ongoing |
| Jun 1, 2024 | Dog | Beagle | Bedinvetmab | Limb weakness; Hind limb paresis; Unable to stand | Ongoing |
| Jun 1, 2024 | Dog | Shepherd Dog - Australian, ... | Bedinvetmab | Weakness; Hind limb ataxia; Overdose | Ongoing |
| Jun 1, 2024 | Cat | Domestic Shorthair | Meloxicam | Decreased appetite; Weight loss; Anaemia NOS; Weakness | Outcome Unknown |
| Jun 1, 2024 | Dog | Hound - Swiss - (Lucerne Ho... | Grapiprant | Walking difficulty; Lethargy (see also Central nervous system depression in N... | Ongoing |
| Jun 1, 2024 | Dog | Dog (other) | Trilostane | Lack of efficacy - NOS; Weakness | Outcome Unknown |
| Jun 1, 2024 | Dog | Dog (unknown) | Bedinvetmab | Excessive thirst; Polyuria; Limb weakness | Outcome Unknown |
| Jun 1, 2024 | Dog | Retriever - Golden | Bedinvetmab | Restlessness; Anxiety; Limb weakness | Recovered/Normal |
| Jun 1, 2024 | Dog | Boxer (German Boxer) | Carprofen | Limb weakness; Gait abnormality | Ongoing |
| Jun 1, 2024 | Dog | Retriever - Labrador | Buprenorphine | Walking difficulty; Fever; Tachycardia; Panting; Proprioception loss; Hypopho... | Ongoing |
| Jun 1, 2024 | Dog | Retriever - Labrador, Dog (... | Bedinvetmab | Limb weakness; Wobbliness; Death by euthanasia | Euthanized |
| Jun 1, 2024 | Dog | Greater Swiss Mountain Dog | Bedinvetmab | Walking difficulty; Lethargy (see also Central nervous system depression in N... | Ongoing |
| Jun 1, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Irritability; Warm feeling to the touch; Behavioural disorder NOS; Restlessne... | Ongoing |
| May 31, 2024 | Dog | Retriever - Golden, Poodle ... | Maropitant Citrate | Medication error NOS; Diarrhoea; Anorexia; Adipsia; Dehydration; Third eyelid... | Euthanized |
| May 31, 2024 | Dog | Terrier - Bull - American Pit | Moxidectin | Vomiting; Disorientation; Nystagmus; Weakness; Wobbliness | Recovered/Normal |
| May 31, 2024 | Dog | Spitz - German Pomeranian, ... | Nitenpyram | Walking difficulty; Weakness; Shaking | Outcome Unknown |
| May 31, 2024 | Dog | Dog (unknown) | Bedinvetmab | Hind limb paresis; Limb weakness; Faecal incontinence | Ongoing |
| May 31, 2024 | Dog | Dog (unknown) | Bedinvetmab | Behavioural disorder NOS; Urinary incontinence; Staggering; Limb weakness; Le... | Outcome Unknown |
| May 30, 2024 | Dog | Retriever - Golden, Poodle ... | Bedinvetmab | Appetite loss; Excessive thirst; Lethargy (see also Central nervous system de... | Died |
| May 30, 2024 | Dog | Beagle | Bedinvetmab | Hind limb paresis; Hind limb ataxia; Muscle weakness NOS | Recovered/Normal |
| May 30, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Vomiti... | Euthanized |
| May 30, 2024 | Cat | Domestic Shorthair | Buprenorphine | Lethargy (see also Central nervous system depression in Neurological); Hiding... | Ongoing |
| May 30, 2024 | Dog | Crossbred Canine/dog | Melarsomine Dihydrochloride | Weakness; Anaphylaxis; Pale mucous membrane; Decreased pulse oxygenation; Tac... | Recovered/Normal |
| May 30, 2024 | Dog | Sheepdog (unspecified) | Bedinvetmab | Panting; Vomiting; Vocalisation; Pale mucous membrane; Anaphylaxis; Agitation... | Recovered/Normal |
| May 30, 2024 | Dog | Spaniel - King Charles Cava... | Bedinvetmab | Restlessness; Cough; Heart murmur; Seizure NOS; Weakness; Glazed eye | Ongoing |
| May 30, 2024 | Dog | Chihuahua | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Hypoth... | Died |
| May 29, 2024 | Dog | Retriever - Labrador, Dog (... | Grapiprant | Limb weakness; Hind limb ataxia | Recovered/Normal |
| May 29, 2024 | Dog | Terrier (unspecified) | Bedinvetmab | Excessive thirst; Frequent urination; Panting; Not sleeping; Head tilt - neur... | Ongoing |
| May 29, 2024 | Dog | Retriever - Labrador, Dog (... | Bedinvetmab | Limb weakness; Hind limb ataxia | Recovered/Normal |
| May 29, 2024 | Dog | Shepherd Dog - Australian | Moxidectin | Emesis (multiple); Anaphylaxis; Diarrhoea; Weakness; Panting; Febrile; Weak p... | Ongoing |
| May 28, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Limb weakness; Ataxia; Hot spot (pyotraumatic dermatitis); Urinary incontinen... | Ongoing |
| May 28, 2024 | Dog | Spaniel - Cocker American, ... | Capromorelin Tartrate | Ataxia; Limb weakness; Decreased appetite; Diarrhoea; Dry eye; Ocular dischar... | Ongoing |
| May 28, 2024 | Dog | Terrier - Yorkshire, Dog (u... | Bedinvetmab | Ataxia; Weakness; Proprioception deficit; Claw / hoof / nail disorder NOS | Ongoing |
| May 28, 2024 | Dog | Terrier - Jack Russell | Moxidectin | Vomiting; Pale mucous membrane; Bradycardia; Panting; Generalised weakness; I... | Recovered/Normal |
| May 28, 2024 | Dog | Greyhound | Bedinvetmab | Pain NOS; Muscle weakness NOS; Collapse NOS (see also Cardio-vascular and Neu... | Ongoing |
| May 28, 2024 | Dog | Ridgeback - Rhodesian, Dog ... | Bedinvetmab | Ataxia; Hemiparesis (weakness L or R side) | Ongoing |
| May 27, 2024 | Dog | Crossbred Canine/dog | Bedinvetmab | Partial lack of efficacy; Unable to walk; Unable to stand; Collapse of leg; N... | Euthanized |
| May 26, 2024 | Dog | Chihuahua, Dachshund - Mini... | Imidacloprid | Emesis; Lethargy (see also Central nervous system depression in Neurological)... | Recovered/Normal |
| May 26, 2024 | Dog | Spitz - German Pomeranian | Lotilaner | Decreased appetite; Lacrimation; Shaking; Weakness | Ongoing |
| May 26, 2024 | Rabbit | Rabbit (other) | Cefovecin | Diarrhoea; Head pressing; Weakness; Seizure NOS; Death; Administration error NOS | Died |
| May 26, 2024 | Dog | American Pit Bull Terrier | Nitenpyram | Lethargy (see also Central nervous system depression in Neurological); Genera... | Outcome Unknown |
| May 25, 2024 | Dog | Newfoundland | Fluralaner 13.64% 12-Week Chew | Difficulty to rise; Walking difficulty; Neck pain - neurological; Shaking; Li... | Ongoing |
| May 25, 2024 | Cat | Domestic Shorthair | Protamine Zinc Recombinant Human Insulin | Vomiting; Generalised weakness; Moribund; Death by euthanasia | Euthanized |
| May 25, 2024 | Dog | Shih Tzu | Bedinvetmab | Limb weakness; Polyuria; Difficulty going up/down stairs; Collapse of leg | Ongoing |
| May 25, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Limb weakness; Hind limb paresis | Ongoing |
| May 25, 2024 | Dog | Dachshund (unspecified) | Bedinvetmab | Not eating; Pain NOS; Not drinking; Unable to stand; Unable to walk; Weakness... | Ongoing |
| May 24, 2024 | Dog | Terrier - Yorkshire | Bedinvetmab | Anorexia; Ataxia; Muscle weakness NOS | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.